FIELD: medicine.
SUBSTANCE: crosslinking is performed simultaneously on both eyes. After anesthetic solution instillation, alcohol corneal deepithelialization 8.5 mm in diameter is performed, stroma is impregnated with 0.1% riboflavin-mononucleotide and dextran solution by instillation, once a minute for 30 minutes, then the cornea of both eyes is exposed to ultraviolet irradiation for another half of an hour, using the following parameters: wavelength 370 nm, beam diameter 8.0 mm, power 6.0 mW/cm2; riboflavin solution at this stage is installed once every 5 minutes, the procedure is completed by soft contact lenses imposition.
EFFECT: method allows to reduce procedure duration, which reduces the number of complications.
2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORNEAL COLLAGEN CROSSLINKING | 2021 |
|
RU2768181C1 |
| CORNEAL COLLAGEN CROSSLINKING AND SIMULTANEOUS IMPLANTATION OF INTRASTROMAL CORNEAL SEGMENTS IN THE PAIRED EYE IN PATIENTS WITH DIFFERENT STAGES OF KERATOCONUS | 2020 |
|
RU2750902C1 |
| METHOD OF TREATMENT OF KERATECTASIA BY THE METHOD OF PULSE ACCELERATED ULTRAVIOLET CROSSLINKING OF CORNEA | 2017 |
|
RU2682494C1 |
| METHOD OF TREATING KERATOCONUS STAGE I-II | 2022 |
|
RU2819801C2 |
| METHOD FOR CONDUCTING ULTRAVIOLET CORNEAL CROSS-LINKING USING BIOLENS WITH THIN CORNEA | 2020 |
|
RU2739995C1 |
| METHOD OF CORNEAL GRAFT PREPARATION FOR LAYER-BY-LAYER KERATOPLASTY | 2019 |
|
RU2723135C1 |
| COMBINED METHOD FOR THE TREATMENT OF CORNEAL DISEASES WITH THE USE OF KERATOPLASTY AND CROSS-LINKING | 2017 |
|
RU2676434C1 |
| OPHTHALMOLOGICAL MEANS FOR ULTRAVIOLET CORNEAL CROSSLINKING | 2016 |
|
RU2646452C1 |
| METHOD OF TREATING CORNEAL ECTATIC DISORDERS | 2013 |
|
RU2510258C1 |
| HYPOSMOTIC OPHTHALMIC MEANS FOR ULTRAVIOLET CROSSLINKING OF THIN CORNEAS | 2016 |
|
RU2631604C1 |
